Table 5.
Aspartate aminotransferase (AST) | Albumin (ALB) | Prothrombin time (PT) | International normalized ratio (INR) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subgroup ID number (I)1 | Subgroup ID number (J)1 | Mean difference (I–J) | Statistical significance (p value2) | Subgroup ID number (I) | Subgroup ID number (J) | Mean difference (I–J) | Statistical significance (p value) | Subgroup ID number (I) | Subgroup ID number (J) | Mean difference (I–J) | Statistical significance (p value) | Subgroup ID number (I) | Subgroup ID number (J) | Mean difference (I–J) | Statistical significance (p value) |
D3 | N | −134.600 | 0.010 | N | B1 | 1.9600 | 0.000 | N | CN1 | −1.79600 | 0.0001 | N | CN1 | −.14600 | 0.0001 |
S3 | 143.600 | 0.008 | C1 | 1.2000 | 0.020 | A1 | −1.01600 | 0.0001 | A1 | −0.08600 | 0.0001 | ||||
A3 | 143.600 | 0.008 | CN1 | B1 | 1.3800 | 0.005 | B1 | −0.95600 | 0.0001 | B1 | −0.07600 | 0.0001 | |||
S1 | B1 | 1.7600 | 0.000 | C1 | −0.97400 | 0.0001 | C1 | −0.07600 | 0.0001 | ||||||
B1 | D1 | −1.2200 | 0.017 | D1 | −0.91600 | 0.0001 | D1 | −0.07600 | 0.0001 | ||||||
N | CN2 | 0.5200 | 0.004 | CN1 | S1 | 1.92000 | 0.0001 | CN1 | S1 | 0.15600 | 0.0001 | ||||
A2 | 0.5000 | 0.007 | A1 | 0.78000 | 0.0001 | A1 | 0.06000 | 0.0001 | |||||||
C2 | 0.9400 | 0.0001 | B1 | 0.84000 | 0.0001 | B1 | 0.07000 | 0.0001 | |||||||
D2 | 0.5800 | 0.001 | C1 | 0.82200 | 0.0001 | C1 | 0.07000 | 0.0001 | |||||||
CN2 | S2 | −0.4400 | 0.028 | D1 | 0.88000 | 0.0001 | D1 | 0.07000 | 0.0001 | ||||||
C2 | 0.4200 | 0.042 | S1 | A1 | −1.14000 | 0.0001 | S1 | A1 | −0.09600 | 0.0001 | |||||
S2 | A2 | 0.4200 | 0.042 | B1 | −1.08000 | 0.0001 | B1 | −0.08600 | 0.0001 | ||||||
C2 | 0.8600 | 0.000 | C1 | −1.09800 | 0.0001 | C1 | −0.08600 | 0.0001 | |||||||
D2 | 0.5000 | 0.009 | D1 | −1.04000 | 0.0001 | D1 | −0.08600 | 0.0001 | |||||||
A2 | C2 | 0.4400 | 0.028 | CN2 | N | −1.03400 | 0.0001 | CN2 | N | −0.08400 | 0.0001 | ||||
B2 | C2 | 0.5800 | 0.002 | S2 | 1.08200 | 0.0001 | S2 | 0.08800 | 0.000 | ||||||
N | A3 | 1.5400 | 0.016 | A2 | 0.73800 | 0.001 | A2 | 0.06000 | 0.001 | ||||||
B3 | 3.1400 | 0.0001 | B2 | 0.77800 | 0.001 | B2 | 0.06000 | 0.001 | |||||||
B3 | CN3 | −2.8400 | 0.000 | C2 | 0.75600 | 0.001 | C2 | 0.06000 | 0.001 | ||||||
S3 | −3.0200 | 0.000 | D2 | 0.80800 | 0.000 | D2 | 0.07000 | 0.000 | |||||||
A3 | −1.6000 | 0.019 | CN3 | N | −0.76200 | 0.001 | CN3 | N | −0.06200 | 0.001 | |||||
C3 | −2.8400 | 0.000 | S3 | 0.81200 | 0.000 | S3 | 0.06600 | 0.000 | |||||||
D3 | −2.4600 | 0.000 | A3 | 0.71800 | 0.000 | A3 | 0.06000 | 0.000 | |||||||
B3 | 0.76200 | 0.000 | B3 | 0.06200 | 0.000 | ||||||||||
C3 | 0.74800 | 0.000 | C3 | 0.06000 | 0.000 | ||||||||||
D3 | 0.79200 | 0.000 | D3 | 0.06800 | 0.000 |
Statistically significant differences between different experimental subgroups, regarding the serum levels of aspartate aminotransferase, albumin, prothrombin time, and international normalized ratio. 1The subgroup ID is depicted in Table 1 (experimental design). 2The level of statistical significance was set at 5% (α = 0.05).